Investor

Shin Nippon Biomedical Laboratories

CVC Domestic (Japan)

Operating company investing from its balance sheet

2026 activity

Classification source: https://prtimes.jp/main/html/rd/p/000000033.000063574.html

Grey amounts aren't counted in totals. † includes debt or other non-equity.

DateCompanyStageAmountInvestorsSector
9 Mar 2026 CICardio Intelligence Series B — Shin Nippon Biomedical LaboratoriesIwagin Business Creation Capital HealthcareDeep tech